Mental Status and Dementia Tests

"Mental Status and Dementia Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tests designed to assess various aspects of neurocognitive function and/or dementia.

Descriptor ID	D000073216
MeSH Number(s)	F04.711.513.603
Concept/Terms	Mental Status and Dementia Tests Mental Status and Dementia Tests MicroCog MicroCog General Practitioner Assessment of Cognition General Practitioner Assessment of Cognition GPCOG Montreal Cognitive Assessment Montreal Cognitive Assessment Mental Status Tests Mental Status Tests Mental Status Test Neurocognitive Tests Neurocognitive Test Dementia Rating Scale Dementia Rating Scale Cognitive Assessment Screening Instrument Cognitive Assessment Screening Instrument Mini-Cog Mini-Cog Clinical Dementia Rating Clinical Dementia Rating Clinical Dementia Rating Scale Unified Parkinson's Disease Rating Scale Unified Parkinson's Disease Rating Scale UPDRS Panel Mini Mental State Examination Mini Mental State Examination MMSE, Mini Mental State Examination Mini Mental Status Examination Folstein Mini-Mental State Examination Neurobehavioral Cognitive Status Examination Neurobehavioral Cognitive Status Examination COGNISTAT

Below are MeSH descriptors whose meaning is more general than "Mental Status and Dementia Tests".

Psychiatry and Psychology [F]
Behavioral Disciplines and Activities [F04]
Psychological Tests [F04.711]
Neuropsychological Tests [F04.711.513]
Mental Status and Dementia Tests [F04.711.513.603]

Below are MeSH descriptors whose meaning is related to "Mental Status and Dementia Tests".

Below are MeSH descriptors whose meaning is more specific than "Mental Status and Dementia Tests".

Mental Status and Dementia Tests
Mental Status Schedule

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Mental Status and Dementia Tests" by people in this website by year, and whether "Mental Status and Dementia Tests" was a major or minor topic of these publications.

Bar chart showing 12 publications over 6 distinct years, with a maximum of 5 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2017	1	0	1
2018	0	2	2
2019	2	3	5
2020	0	2	2
2021	0	1	1
2022	0	1	1

Below are the most recent publications written about "Mental Status and Dementia Tests" by people in Profiles.

Early ML, Linton E, Bosch A, Campbell T, Hill-Briggs F, Pecker LH, Lance EI, Lanzkron S. The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains. Br J Haematol. 2022 07; 198(2):382-390.

View in: PubMed
Weiss J, Rabinowitz AR, Deshpande SK, Hasegawa RB, Small DS. Participation in Collision Sports and Cognitive Aging Among Swedish Twins. Am J Epidemiol. 2021 12 01; 190(12):2604-2611.

View in: PubMed
Ghetti S, Kuppermann N, Rewers A, Myers SR, Schunk JE, Stoner MJ, Garro A, Quayle KS, Brown KM, Trainor JL, Tzimenatos L, DePiero AD, McManemy JK, Nigrovic LE, Kwok MY, Perry CS, Olsen CS, Casper TC, Glaser NS. Cognitive Function Following Diabetic Ketoacidosis in Children With New-Onset or Previously Diagnosed Type 1 Diabetes. Diabetes Care. 2020 11; 43(11):2768-2775.

View in: PubMed
Jutkowitz E, Van Houtven CH, Plassman BL, Mor V. Willingness to Undergo a Risky Treatment to Improve Cognition Among Persons With Cognitive Impairment Who Received an Amyloid PET Scan. Alzheimer Dis Assoc Disord. 2020 Jan-Mar; 34(1):1-9.

View in: PubMed
Black CM, Woodward M, Ambegaonkar BM, Philips A, Pike J, Jones E, Husbands J, Khandker RK. Quantifying the diagnostic pathway for patients with cognitive impairment: real-world data from Australia. Int Psychogeriatr. 2020 05; 32(5):601-610.

View in: PubMed
Black CM, Ambegaonkar BM, Pike J, Jones E, Husbands J, Khandker RK. The Diagnostic Pathway From Cognitive Impairment to Dementia in Japan: Quantification Using Real-World Data. Alzheimer Dis Assoc Disord. 2019 Oct-Dec; 33(4):346-353.

View in: PubMed
Nair AK, Ramaswamy S, Kan K, Nair S. Identifying an Optimal Cutoff of the Montreal Cognitive Assessment to Predict Amyloid-PET Positivity in a Referral Memory Clinic. Alzheimer Dis Assoc Disord. 2019 Jul-Sep; 33(3):194-199.

View in: PubMed
Caccese JB, DeWolf RM, Kaminski TW, Broglio SP, McAllister TW, McCrea M, Buckley TA. Estimated Age of First Exposure to American Football and Neurocognitive Performance Amongst NCAA Male Student-Athletes: A Cohort Study. Sports Med. 2019 Mar; 49(3):477-487.

View in: PubMed
Khosravi M, Peter J, Wintering NA, Serruya M, Shamchi SP, Werner TJ, Alavi A, Newberg AB. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A?Global Quantitative Analysis. J Alzheimers Dis. 2019; 70(4):1197-1207.

View in: PubMed
Zheng DD, Swenor BK, Christ SL, West SK, Lam BL, Lee DJ. Longitudinal Associations Between Visual Impairment and Cognitive Functioning: The Salisbury Eye Evaluation Study. JAMA Ophthalmol. 2018 09 01; 136(9):989-995.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement